Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model.
暂无分享，去创建一个
K. Griffith | S. Schuetze | W. Stadler | E. Davis | R. Chugh | S. Undevia | D. Thomas | B. Brockstein | J. D. Zavala | G. Metko | Bruce Brockstein | E. J. Davis | Dafydd G. Thomas | Walter M. Stadler | Kent A. Griffith | Elizabeth J. Davis | B. Brockstein